I view my responsibility in treating each child as a sacred trust and know that I’m participating in the care for the most important person in the parents’ world.
Daniel J. Lovell, MD, MPH



Since I was 10 years old, I knew I wanted to be a doctor, and I am forever grateful that I stayed with my ambition. I came to pediatrics because I find it truly compelling to help children. I treat each child the same way I would want one of my own children to be treated if they had a rheumatic disease. I view my responsibility in treating each child as a sacred trust and know that I’m participating in the care for the most important person in the parents’ world.

I chose rheumatology after a patient in the hospital where I trained in pediatrics was admitted with juvenile idiopathic arthritis. There was no one at that hospital that specialized in pediatric rheumatology. As I learned then, and it is still true today, there are always at least 10 states in the U.S. without even one pediatric rheumatologist. The need was obvious.

In my practice, I specialize in the evaluation and care of children with rheumatic and related diseases, such as arthritis, lupus, dermatomyositis, scleroderma and various types of vasculitis.

The care of children with rheumatic diseases requires a team of healthcare providers including rheumatologists and other medical specialists, occupational and physical therapists, specialized nurses and social workers. In our Rheumatology Clinic, we have such a team, and every team member was hand-picked for their dedication and experience in caring for children with a rheumatic disease.

Our division is truly committed to providing the most sophisticated and effective therapy in the world for children with rheumatic diseases. This has been a core value of the Division of Rheumatology since it was founded.

I have received three awards that are most dear to me. I am the Joseph E. Levinson Endowed Chair in Pediatric Rheumatology, which is an award from the Cincinnati Children’s Hospital Research Foundation. Dr. Joseph Levinson founded this Division of Rheumatology and was my first boss in my first job as a pediatric rheumatologist. Over time, he became my mentor and friend. I am truly honored to hold a position named after him.

I received the 2019 James Cassidy Award from the American Academy of Pediatrics. Early in my career, I was given the Earl Brewer Research Award from the Arthritis Foundation. I was blessed enough to know and work with both Drs. Cassidy and Brewer, who were founding fathers of our specialty in North America.

My entire research career has been focused on identifying and evaluating more effective treatments for children with rheumatic diseases. I chair an international network of pediatric rheumatology centers called the Pediatric Rheumatology Collaborative Study Group (PRCSG). All the new therapies approved by the Food and Drug Administration for use in the treatment of children with rheumatic diseases in the last 30 years were approved based on studies performed by the PRCSG.

In my free time, my favorite thing to do is to ride horses in the Teton Wilderness. I’ve learned the hard way how to ride for six to eight hours per day. I also love being a grandfather and find it to be a wonderful, never-ending source of joy.

MD: University of Kansas, Kansas City, KS, 1978.

MPH: University of Texas School of Public Health, Houston, TX, 1982.

Residency: Children's Mercy Hospital, Kansas City, KS.

Fellowship: Baylor College of Medicine, Houston, TX.

Certification: Pediatrics, 1984; Pediatric Rheumatology, 1992.


Diagnostic evaluation and ongoing care of children with all pediatric onset rheumatic diseases

Services and Specialties

Rheumatology, Lupus


Performance of clinical trials in children with rheumatic diseases; clinical trials methodology; mentoring of junior faculty

Research Areas


Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information


Diagnostic Accuracy Study of the Pediatric-Specific Ultrasound Scoring System for the Knee Joint in Children With Juvenile Idiopathic Arthritis. Vega-Fernandez, P; Rogers, K; Sproles, A; Thornton, S; Huggins, J; Lovell, DJ; Cassedy, A; Meyers, AB; Ting, TV. Arthritis Care and Research. 2024; 76:251-258.

The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset still's disease. Nigrovic, PA; de Benedetti, F; Kimura, Y; Lovell, DJ; Vastert, SJ. Pediatric Rheumatology Online Journal. 2024; 21:114.

Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic Arthritis. Bingham, CA; Harris, JG; Qiu, T; Gilbert, M; Vora, SS; Yildirim-Toruner, C; Ferraro, K; Lovell, DJ; Taylor, J; Mannion, ML; Batthish, M; Hazen, MM; Spencer, CH; Morgan, EM. Arthritis Care and Research. 2023; 75:2442-2452.

Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA): study protocol for a randomized pragmatic trial. Weiss, PF; Sears, CE; Brandon, TG; Forrest, CB; Neu, E; Kohlheim, M; Leal, J; Xiao, R; Lovell, D. Trials. 2023; 24:100.

Panuveitis and optic neuropathy following SARS-COV-2 in the absence of multisystem inflammatory syndrome in a child. Land, P; Shah, V; Lovell, DJ; Miraldi Utz, V. American Journal of Ophthalmology Case Reports. 2023; 32:101876.

Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials. Ruperto, N; Lovell, DJ; Berman, A; Anton, J; Viola, DO; Lauwerys, B; Rama, ME; Bohnsack, J; Breedt, J; Fischbach, M; Wong, R; Askelson, M; Martini, A; Brunner, HI. The Journal of rheumatology. 2023; 50:1471-1480.

Long-Term Maintenance of Clinical Responses by Individual Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Abatacept. Brunner, HI; Tzaribachev, N; Louw, I; Calvo Penades, I; Avila-Zapata, F; Horneff, G; Foeldvari, I; Kingsbury, DJ; Paz Gastanaga, ME; Wouters, C; Zhuo, J; Martini, A; Lovell, DJ; Ruperto, N. Arthritis Care and Research. 2023; 75:2259-2266.

Paediatric rheumatologists do not score the physician's global assessment of juvenile idiopathic arthritis disease activity in the same way. Backström, M; Tarkiainen, M; Gottlieb, BS; Trincianti, C; Qiu, T; Morgan, E; Lovell, DJ; Bovis, F; Löyttyniemi, E; Ruperto, N; Vähäsalo, P; Consolaro, A. Rheumatology. 2023; 62:3421-3426.

Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial Design. Schanberg, LE; Mulugeta, L; Akinlade, B; Brunner, HI; Chen, J; Colbert, RA; Delgaizo, V; Gastonguay, MR; Glaser, R; Imundo, L; Singh, R; Sinha, V; Yancey, CL; Yao, L. Arthritis and Rheumatology. 2023; 75:1856-1866.

Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III Study. Ruperto, N; Lovell, DJ; Berman, A; Ávila-Zapata, F; Horneff, G; Alessio, M; Becker, ML; Belot, A; Burgos-Vargas, R; Gamir, ML; Askelson, M; Wong, R; Martini, A; Brunner, HI. Arthritis Care and Research. 2023; 75:1804-1814.

From the Blog

Lovell Receives ACR Distinguished Service Award
Autoimmune Disorders

Lovell Receives ACR Distinguished Service Award

Daniel J. Lovell, MD, MPH12/9/2022

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Overall Patient Rating